# Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery

> **NCT05149495** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 100 (estimated)

## Conditions studied

- Acromegaly

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05149495
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-03
- **Final completion:** 2023-03-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149495, "Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05149495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*